EP1736539 - Attenuated SARS-CoV vaccines [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.02.2008 Database last updated on 22.08.2024 | Most recent event Tooltip | 22.02.2008 | Application deemed to be withdrawn | published on 26.03.2008 [2008/13] | Applicant(s) | For all designated states CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS C/ Serrano 117 28006 Madrid / ES | [N/P] |
Former [2006/52] | For all designated states CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS Serrano, 117 28006 Madrid / ES | Inventor(s) | 01 /
Álvarez Gómez, Enrique C/ Santiago de Compostela, 88 8[deg] G 28035 Madrid / ES | 02 /
López de Diego, Marta C/ Castilla la Mancha, n[deg] 146 28700 San Sebastián de los Reyes, Madrid / ES | 03 /
Enjuanes Sanches, Luis Camino Nuevo, 113 La Moraleja 28109 Madrid / ES | 04 /
Almazán Toral, Fernando C/ La del Soto del Parral 1, 1A 28041 Madrid / ES | [2006/52] | Representative(s) | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstrasse 4 22607 Hamburg / DE | [N/P] |
Former [2006/52] | UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE | Application number, filing date | 05013727.2 | 24.06.2005 | [2006/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1736539 | Date: | 27.12.2006 | Language: | EN | [2006/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.03.2006 | Classification | IPC: | C12N7/04, A61K39/215, A61P11/00 | [2006/52] | CPC: |
A61K39/215 (EP);
A61K39/12 (EP);
A61P11/00 (EP);
C07K14/005 (EP);
C12N7/00 (EP);
A61K2039/5254 (EP);
A61K2039/53 (EP);
C12N2770/20022 (EP);
C12N2770/20034 (EP);
C12N2770/20061 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/52] | Title | German: | Abgeschwächte SARS-CoV Impfstoffe | [2006/52] | English: | Attenuated SARS-CoV vaccines | [2006/52] | French: | Vaccins comprenant le SARS-CoV atténué | [2006/52] | Biological material | This application mentions deposited biological material, check the file for details | Examination procedure | 28.06.2007 | Application deemed to be withdrawn, date of legal effect [2008/13] | 06.11.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2008/13] | Fees paid | Renewal fee | 14.06.2007 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2004085633 (UNIV HONG KONG [CN]) [Y] 1-3,6-23 * pages 20-24; sequence 15 *; | [Y]WO2004091524 (ACAMBIS INC [US], et al) [Y] 1-3,6-23 * the whole document *; | [Y] - HUANG Y ET AL, "GENERATION OF SYNTHETIC SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS PSEUDOPARTICLES: IMPLICATIONS FOR ASSEMBLY AND VACCINE PRODUCTION", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200411), vol. 78, no. 22, ISSN 0022-538X, pages 12557 - 12565, XP009046697 [Y] 1-3,6-23 * the whole document * DOI: http://dx.doi.org/10.1128/JVI.78.22.12557-12565.2004 | [Y] - KUO LILI ET AL, "The small envelope protein E is not essential for murine coronavirus replication.", JOURNAL OF VIROLOGY, (200304), vol. 77, no. 8, ISSN 0022-538X, pages 4597 - 4608, XP002359410 [Y] 1-3,6-23 * the whole document * DOI: http://dx.doi.org/10.1128/JVI.77.8.4597-4608.2003 | [Y] - HE Y ET AL, "Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20041210), vol. 325, no. 2, ISSN 0006-291X, pages 445 - 452, XP004626814 [Y] 1-3,6-23 * the whole document * DOI: http://dx.doi.org/10.1016/j.bbrc.2004.10.052 | [Y] - ZHANG C-H ET AL, "Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20050502), vol. 23, no. 24, ISSN 0264-410X, pages 3196 - 3201, XP004851707 [Y] 1-3,6-23 * the whole document * DOI: http://dx.doi.org/10.1016/j.vaccine.2004.11.073 | [ ] - "hSARS virus genome, SEQ ID 15.", Geneseq, (20041230), Database accession no. ADT36557, URL: EBI | [ ] - "SARS coronavirus Urbani strain complete genome.", Geneseq, (20050113), Database accession no. ADT08491, URL: EBI |